Results 161 to 170 of about 28,984 (253)

Factors requiring adaptive re-planning in carbon ion radiotherapy for head and neck cancers. [PDF]

Front Oncol
Yamada T, Okano N, Matsumura A, Sakai M, Shimada H, Musha A, Ohno T.   +6 more
europepmc   +1 more source

Protein glycosylation in lung cancer from a mass spectrometry perspective

Mass Spectrometry Reviews, Volume 45, Issue 3, Page 455-475, May/June 2026.
ABSTRACT Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi, Simon Sugár, Lilla Turiák   +2 more
wiley   +1 more source

Evaluation and implementation of an independent Kilovoltage X-ray-based imaging platform for carbon ion radiotherapy. [PDF]

J Appl Clin Med Phys
Guo Y, Liu Z, Zhu Q, Cai M, Cai H, Liu R, Zhang Q, Xu Z.   +7 more
europepmc   +1 more source

Cerebral Hemodynamic Changes During Cardiac Surgery: A Feasibility MR Study in Piglets

NMR in Biomedicine, Volume 39, Issue 5, May 2026.
Congenital heart disease surgery in infants requires cardiopulmonary bypass (CPB), which increases the risk of brain injury. Conventional heart‐lung machines (HLMs) cannot operate inside MRI scanners, limiting real‐time assessment of cerebral changes. We developed an MR‐conditional HLM and tested it in piglets during CPB.
Dominik T. Schulte, Ruth O'Gorman Tuura, Henning Richter, Michael Hofmann, Francesca del Chicca, Tobias Aigner, Christoph Loeschmann, Martina Lentini, Manuela Wieser, Frauke Seehusen, Rima Bektas, Melanie Zeilinger, Martin O. Schmiady, Marianne Schmid Daners   +13 more
wiley   +1 more source

Commissioning and robustness evaluation of external laser sensor for respiratory gating in carbon-ion radiotherapy. [PDF]

J Appl Clin Med Phys
Kim TH, Han S, Yoo D, Lee S, Oh T, Lee D, Kim C, Han MC, Hong CS, Kim JS.   +9 more
europepmc   +1 more source

Carbon Ion Radiotherapy - Chiba Experience

Carbon Ion Radiotherapy - Chiba Experience
Carbon ion radiotherapy (CIRT) is a unique radiotherapy, which possesses well localized and superior depth dose distribution in addition to uniform, less repairable radiobiological effects. The use of CIRT for various diseases has been explored as clinical trials at the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan, since 1994.
openaire  

Defining the tumor microenvironment of non‐small cell lung cancer

Immunology &Cell Biology, Volume 104, Issue 5, Page 499-518, May‐June 2026.
The tumor microenvironment (TME) in non‐small cell lung cancer is highly heterogeneous, both at a patient level and tumor microenvironment resolution. Defining the tumor microenvironment from patient‐responders and non‐responders will aid in the development of targeted therapeutics specific for each individual patient.
Kidane Siele Embaye, Tony Blick, Vahid Yaghoubi Naei, Ken O'Byrne, Brett G. M. Hughes, Arutha Kulasinghe   +5 more
wiley   +1 more source

Carbon Ion Radiotherapy for Retroperitoneal Sarcoma: A Single-Institution Study. [PDF]

Cancers (Basel)
Imai R, Yonemoto T, Araki N, Takiyama H, Ikawa H, Yamada S, Ishikawa H.   +6 more
europepmc   +1 more source

Pathophysiology and Molecular Signalling in Osteoporosis: Linking Risk Factors to Bone Loss

Journal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Osteoporosis is a prevalent skeletal disorder characterised by progressive reduction in bone mass, microarchitectural deterioration, and increased fracture susceptibility. In India, approximately one‐third of the elderly population is affected by bone‐related disorders, and the global burden of osteoporosis continues to rise.
Pramoda G., Kamini Shivhare, Piyush Kumar Gupta, Amirhossein Sahebkar, Prashant Kesharwani, Rahul Shukla   +5 more
wiley   +1 more source

Clinical outcomes of carbon-ion radiotherapy for residual or recurrent hepatocellular carcinoma after transarterial chemoembolization. [PDF]

ESMO Gastrointest Oncol
Sekiguchi Y, Shibuya K, Tomogane S, Miyasaka Y, Kakizaki S, Okamoto M, Araki K, Shirabe K, Ohno T.   +8 more
europepmc   +1 more source